Dr. Adam D. Horvit, MD

Dr. Horvit practices at Central Texas Neurology Consultants in Round Rock, Texas.

Dr. Horvit's NPI, 1578590105, was assigned on June 27, 2006. Dr. Horvit graduated from Baylor College Of Medicine in 1992. Dr. Horvit holds Texas license J4217.

Dr. Horvit's primary practice is Central Texas Neurology Consultants, at 16040 Park Valley Dr, Round Rock, TX 78681. The practice phone is (512) 218-1222.

Dr. Horvit's primary practice is Central Texas Neurology Consultants in Round Rock, Texas. Dr. Horvit is also affiliated with St. David's Round Rock Medical Center. The medical group on file is Central Texas Neurology Consultants. Dmand AI also links Dr. Horvit to 2 more hospitals, each named with a free account. Dr. Horvit's employer is on file too: a physical therapy & rehab clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Horvit practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Horvit's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Horvit is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Horvit is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and hereditary polyneuropathy among the conditions Dr. Horvit treats.

CMS data shows 1,025 Medicare services from Dr. Horvit across 8 procedure codes in 2024, for 496 Medicare patients. Medicare paid $88,447 for them. Every service was in an office.

CMS counts 496 Medicare patients who saw Dr. Horvit in 2024. The largest group is 75 to 84, with 241 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Horvit's median patient age at 69, with 52% women.

In 2024, Dr. Horvit wrote 2,102 Medicare Part D claims for 363 patients. 96% of them were for generic drugs. CMS names the drug for 1,918 of them, across 26 drugs with 11 or more claims each, at $315,290 in total drug cost. In 2023, CMS named 1,764 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Horvit for performance year 2024, reported individually. Dr. Horvit accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Horvit in 2025.

Dmand AI links Dr. Horvit to 1 clinical trial. Conditions studied include Myasthenia Gravis and Neuromuscular Junction Diseases. Open Payments lists research payments to Dr. Horvit that name 1 trial.

CMS Open Payments shows 583 general payments to Dr. Horvit from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Alexion Pharmaceuticals, Inc. paid the most, $41,912. It also lists 4 research payments totaling $1,046 in 2019, naming 1 clinical trial.

Dr. Horvit graduated from Baylor College Of Medicine in 1992.

Dr. Horvit is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.